Expert Series Q&A: with Dr Mary Ann Anderson
Dr Anderson was one of the key researchers involved in the discovery of the live-changing drug, venetoclax (Venclexta®).
- Acute myeloid leukaemia
- Chronic lymphocytic leukaemia
- Interviews with experts
Dr Anderson was one of the key researchers involved in the discovery of the live-changing drug, venetoclax (Venclexta®).
We spoke to Professor Con Tam on the latest in CLL research.
We had an in-depth chat with the Head of Haematology at Concord Repatriation General Hospital in Sydney about her career highlights, lymphoma research news and how her international collaborative group, Women in Lymohonma is instigating change.
Professor David Ross discusses the "massive explosion" of recent clinical trial activity in MPN.
Expert interview series: Associate Professor Peter Mollee discusses issues around AL amyloidosis
The researcher and haematologist takes us on a deep dive into chronic myeloid leukaemia.
The mind play an enormous role in your health.